{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16"}]}],"title":"Day 100 : NY-ESO-1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"16"}]}],"title":"Day 100 : LAGE or LAGE-1a"},{"categories":[{"measurements":[{"groupId":"OG000","value":"14"}]}],"title":"Day 180 : NY-ESO-1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"14"}]}],"title":"Day 180 : LAGE or LAGE-1a"}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"}],"units":"Participants"}],"description":"Number of participants with NY-ESO-1 and LAGE or LAGE-1a expression in the marrow post-infusion","groups":[{"description":"Participants who received NYESO-1ᶜ²⁵⁹T following ASCT with data at pre-and post-infusion time points","id":"OG000","title":"NYESO-1ᶜ²⁵⁹T Cells"}],"paramType":"NUMBER","populationDescription":"Participants who received NYESO-1ᶜ²⁵⁹T following ASCT with expression data at all points.","reportingStatus":"POSTED","timeFrame":"Pre- and post-infusion","title":"Marrow Antigen Expression Pre-and Post-infusion","type":"SECONDARY","unitOfMeasure":"participants"}